|
|
||||
|
India Wants to be Your Biotech Source
A greater respect for intellectual property could boost India's ability to compete in 2005
The Scientist 2004, 18(20):51
|
||||
|
|
||||
|
Low costs. Skilled workers. New patent protections. A ready pool of patients for clinical trials. These are the ingredients contributing to India's blossoming biotechnology industry, which grew by nearly 40% last year and is now second only to the United States in its number of FDA-approved drug manufacturing plants. India boasts more than $700 million in annual revenues from its biotechnology industry.
|